Buy RMD now and get great upside returns in a year or two, page-146

shares ticked up after hours on third-quarter results that came in ahead of the consensus forecast.Shares of RMD rose more than 4% to $191 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day down 1%.The San Diego-based respiratory device maker reported profits of $300.5 million. That equals $2.04 per share on sales of $1.197 billion for the quarter ended March 31, 2024.ResMed recorded a 29.2% bottom-line gain on a sales increase of 7.2%.Adjusted to exclude one-time items, earnings per share came in at $2.13. That landed 22¢ ahead of expectations on Wall Street. Sales also topped the forecast as experts estimated $1.17 billion in revenue.